26 May 2021
Testosterone treatment in men with obesity and type 2 diabetes may decrease their risk of developing non-alcoholic fatty liver disease, according to a study presented at the recent European Congress of Endocrinology.
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024